Format

Send to

Choose Destination
Clin Interv Aging. 2013;8:749-63. doi: 10.2147/CIA.S37738. Epub 2013 Jun 21.

Polypharmacy in the HIV-infected older adult population.

Author information

1
Division of Geriatrics and Aging, Highland Hospital, Rochester, NY 14620, USA.

Abstract

The prevalence of human immunodeficiency virus (HIV) infection among people older than 50 years is increasing. Older HIV-infected patients are particularly at risk for polypharmacy because they often have multiple comorbidities that require pharmacotherapy. Overall, there is not much known with respect to both the impact of aging on medication use in HIV-infected individuals, and the potential for interactions with highly active antiretroviral therapy (HAART) and coadministered medications and its clinical consequences. In this review, we aim to provide an overview of polypharmacy with a focus on its impact on the HIV-infected older adult population and to also provide some clinical considerations in this high-risk population.

KEYWORDS:

HIV; older adults; polypharmacy

PMID:
23818773
PMCID:
PMC3693722
DOI:
10.2147/CIA.S37738
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center